Showing results (161-170 of 276) with videos related to

Sort By:
Pageof 28
JAMA Oncology|October 8, 2020
Effect of Weekly Paclitaxel With or Without Bevacizumab on Progression-Free Rate Among Patients With Relapsed Ovarian Sex Cord-Stromal Tumors: The ALIENOR/ENGOT-ov7 Randomized Clinical TrialIsabelle Ray-Coquard, Philipp Harter, Domenica Lorusso, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 14, 2022
Impact of substage and histologic type in stage I ovarian carcinoma survival: a multicenter retrospective observational studyMajdi Imterat, Nicolò Bizzarri, Robert Fruscio, et al.
JCO Precision Oncology|June 12, 2026
Constitutional <i>BRCA1</i> Promoter Methylation in Patients With Ovarian Cancer: Results of the Observational AGO-TR1 StudyMohamad Kayali, Eric Hahnen, Alexander Burges, et al.
Gynecologic Oncology|October 18, 2025
Development and optimization of an integrated exercise and nutrition program for ovarian cancer patients: Phase I of the BENITA multi-center studyTabea Maurer, Matthias H Belau, Birgit-Christiane Zyriax, et al.
Journal of the National Cancer Institute|December 29, 2020
Concordance Between Tumor and Germline BRCA Status in High-Grade Ovarian Carcinoma Patients in the Phase III PAOLA-1/ENGOT-ov25 TrialCéline Callens, Dominique Vaur, Isabelle Soubeyran, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 9, 2023
Adult ovarian granulosa cell tumors: analysis of outcomes and risk factors for recurrenceHelmut Plett, Enzo Ricciardi, Vlad Vacaru, et al.
Gynecologic Oncology|March 2, 2021
Age, treatment and prognosis of patients with squamous cell vulvar cancer (VSCC) - analysis of the AGO-CaRE-1 studyKatharina Prieske, Linn Woelber, Mustafa Zelal Muallem, et al.
Annals of Surgical Oncology|July 7, 2011
A risk model for secondary cytoreductive surgery in recurrent ovarian cancer: an evidence-based proposal for patient selectionWen-Juan Tian, Dennis S Chi, Jalid Sehouli, et al.
Plos One|February 7, 2022
Cell-free tumor DNA, CA125 and HE4 for the objective assessment of tumor burden in patients with advanced high-grade serous ovarian cancerFlorian Heitz, Sotirios Lakis, Philipp Harter, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 25, 2024
Impact of metformin, statins, and beta blockers on survival in patients with primary ovarian cancer: combined analysis of four prospective trials of AGO-OVAR and ENGOT/GCIG collaboratorsDominik Denschlag, Florian Heitz, Jacobus Pfisterer, et al.
Pageof 28